Search at Vanderbilt-Ingram Cancer Center

1091 results found

Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Relevance: 1

A Phase 1 Study of AB521 in Renal Cell Carcinoma and Other Solid Tumors

Relevance: 1

Nivolumab and Ipilimumab for the Treatment of Patients with Locally Advanced, Metastatic, or Unresectable Liver Cancer

Relevance: 1

Avelumab or Hydroxychloroquine with or without Palbociclib for the Treatment of Stage II-III Breast Cancer, PALAVY Study

Relevance: 1

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Relevance: 1

Vorinostat in Preventing Graft Versus Host Disease in Children, Adolescents, and Young Adults Undergoing Blood and Bone Marrow Transplant

Relevance: 1

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Relevance: 1

A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

Relevance: 1

RBS2418 Evaluation in Subjects With Unresectable or Metastatic Tumors

Relevance: 1

Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

Relevance: 1